MVP vs NOX

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

MVP

MEDICALDEV FPO [MVP]

62MEDIUM-HIGH

NOX

NOXOPHARM FPO [NOX]

53MEDIUM

Score Breakdown

MVP NOX
Technical
68
57
Catalyst
50
55
Sentiment
50
50
Fundamental
95
37
Momentum
51
54
Risk Gate
50
46

Key Metrics

MVP Metric NOX
$52.9MMarket Cap$24.9M
214KAvg Volume (20d)77K
N/AShort InterestN/A
$0.76552-Week High$0.110
$0.36552-Week Low$0.051
+2.2%Daily Change-1.2%
$0.460Reference Price$0.080
+1.1%ROEN/A
+1.5%Profit MarginN/A

Active Signals

MVP Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (1.2x)
●Moderate revenue growth (+10%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

NOX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Drifting lower — down 4.8% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (0.4 quarters)
●4C filed 2026-07-21
●Piotroski F-Score weak (2/9, low-confidence approx)

Ask Scout AI to compare MVP and NOX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

RHT vs SOM →ACL vs MVP →AHC vs CMP →AHC vs PIQ →ARX vs EYE →
MVP Full Analysis → NOX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).